Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

431
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

Auscandoc

Safety and Immunogenicity of Spike Protein in and in India: A Phase 2-3 Randomized Clinical Trial | Vaccination | JAMA Pediatrics | JAMA Network jamanetwork.com/journals/jamap “SII-NVX-CoV2373 was safe and well tolerated in children and adolescents in this study. The vaccine was highly immunogenic and may be used in against COVID-19.”

jamanetwork.comSafety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in IndiaThis phase 2-3 randomized clinical trial evaluates the noninferiority of SII-NVX-CoV2373 in children and adolescents compared with adults and the safety of SII-NVX-CoV2373 compared with placebo.
Aug 04, 2023, 02:57 PM·Public·Mona for iPhone
1boost·2favorites
ExploreLive feeds
About